VCM
WVE icon

Versant Capital Management’s Wave Life Sciences WVE Stock Holding History

Versant Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$895 Buy
+154
New +$1.02K ﹤0.01% 2651
2025
Q4 		– Sell
-108
Closed -$791 – 2752
2025
Q3 		$791 Buy
+108
New +$874 ﹤0.01% 2528

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Versant Capital Management's WVE Position: Q2 2026 in Review

Versant Capital Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 154 shares worth $895. The stake represents ﹤0.01% of the portfolio and ranks #2651 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in WVE as recently as Q3 2025.

Versant Capital Management first reported a position in WVE in Q3 2025 and has held it in 2 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Versant Capital Management held 154 shares of Wave Life Sciences worth $895 as of Q2 2026.
  • Wave Life Sciences was a new Versant Capital Management position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2651 holding.
  • Versant Capital Management first reported a position in Wave Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.